The main aPL antibodies in APS patients are lupus anticoagulant (LAC), anti-cardiolipin (aCL) and anti-β2-glycoprotein-I (aβ2GPI) antibodies. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.